GS
65
16
SJM
17
5
FMC
23
7
AN
49
2
CHRW
53
2
ESS
44
5
AIV
39
6
NSC
33
6
AAP
26
5
GOOG
77
14
EFX
43
3
STT
48
4
SPG
45
2
DHI
36
3
NWSA
69
4
ZTS
38
4
MMC
46
5
KEY
24
2
TGT
35
4
CI
35
2
GS
65
16
SJM
17
5
FMC
23
7
AN
49
2
CHRW
53
2
ESS
44
5
AIV
39
6
NSC
33
6
AAP
26
5
GOOG
77
14
EFX
43
3
STT
48
4
SPG
45
2
DHI
36
3
NWSA
69
4
ZTS
38
4
MMC
46
5
KEY
24
2
TGT
35
4
CI
35
2
Financhill
Back

SPDR Portfolio Emerging Markets ETF Vs. Novo Nordisk AS Industry Stock Comparison

Buy
53

SPEM
SPDR Portfolio Emerging Markets ETF

Last Price:
$39.30
Seasonality Move:
0.32%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Buy
53
SPDR Portfolio Emerging Markets ETF (SPEM) is a Buy

Is SPDR Portfolio Emerging Markets ETF a Buy, Sell or Hold?

  • The current SPDR Portfolio Emerging Markets ETF [SPEM] share price is $39.29. The Score for SPEM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • SPEM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SPEM Stock Price Chart

What is SPDR Portfolio Emerging Markets ETF's stock price today?

  • The SPDR Portfolio Emerging Markets ETF share price today is $39.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPEM is experiencing slight buying pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

SPEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 42.68 Sell
Chaikin Money Flow: 489025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.15 - 40.19) Sell
Bollinger Bands (100): (38.12 - 41) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

SPEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.74 Sell
20-day SMA: 39.76 Sell
50-day SMA: 40.13 Sell
200-day SMA: 38.42 Buy
8-day EMA: 39.58 Sell
20-day EMA: 39.77 Sell
50-day EMA: 39.87 Sell
200-day EMA: 38.51 Buy

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

SPDR Portfolio Emerging Markets ETF Earnings Growth & SPEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

SPDR Portfolio Emerging Markets ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):